Lyfe Rx review
Compounded semaglutide at $225/mo and tirzepatide at $299/mo, shipped everywhere except Alabama — but the FDA issued Lyfe Rx its own FDA warning letter on 09/09/2025 for false or misleading claims about these exact products, confirmed directly on FDA.gov and never mentioned by the site itself.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Lyfe Rx at a glance
- Semaglutide
- $225/mo
- Tirzepatide
- $299/mo
- Coverage
- All states except Alabama
- Brand-name
- Compounded only
How we scored Lyfe Rx
Each score comes out of Lyfe Rx's published pricing, disclosures and oversight, and the six combine into the 39/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- www.thelyferx.com
$225 and $299, with no promotional rate attached, everywhere except Alabama. The FDA wrote to thelyferx.com on 9 September 2025, finding its claims about compounded semaglutide and tirzepatide false or misleading. The site mentions this nowhere in its own copy, which is precisely why it appears here.
What to expect when you sign up
We walked Lyfe Rx's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The pricing and FAQ pages render fully on a plain page load
- 2Regular pricing is stated directly on the page, ahead of account creation
- 3The site itself makes no mention of its own FDA warning letter — that fact came from FDA.gov, not the provider's own copy
What we noticed
- The FDA issued Lyfe Rx an FDA warning letter dated 09/09/2025, addressed to thelyferx.com by name, for misbranding under FDCA sections 502(a) and 502(bb) — the letter found the site's claims about compounded semaglutide and tirzepatide false or misleading
- The site displays a LegitScript Certified badge and states it ships everywhere except Alabama
- No account was created and no checkout completed — pricing facts come from the public site; the regulatory finding comes from FDA.gov
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $225 | Compounded semaglutide |
| Compounded tirzepatide | $299 | Compounded tirzepatide |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Lyfe Rx's public disclosures at last review and change often; confirm the current number on Lyfe Rx's own site.
What we like
- Broad coverage — ships everywhere except Alabama
- Both molecules available on one site
- LegitScript Certified badge displayed
- Pricing stated plainly, no bait-and-switch first month found
The caveats
- The FDA issued Lyfe Rx an FDA warning letter dated 09/09/2025 for false or misleading claims about its compounded semaglutide/tirzepatide products — confirmed on FDA.gov
- The site makes no mention of the warning letter anywhere in its own copy
- Not available in Alabama
- Nothing on family budgeting, pregnancy, breastfeeding, or postpartum recovery
Lyfe Rx for mothers: our verdict
Compounded semaglutide at $225/mo and tirzepatide at $299/mo, shipped everywhere except Alabama — but the FDA issued Lyfe Rx its own FDA warning letter on 09/09/2025 for false or misleading claims about these exact products, confirmed directly on FDA.gov and never mentioned by the site itself. It runs about $225/month, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh Lyfe Rx the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Lyfe Rx actually costs
- Compounded semaglutide — Compounded semaglutide: $225/mo
- Compounded tirzepatide — Compounded tirzepatide: $299/mo
For context, the typical ongoing price across our roster is around $179/month, so Lyfe Rx sits at the premium end.
The medications Lyfe Rx prescribes
Lyfe Rx prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Lyfe Rx fits — and where it doesn't — for mothers
Worth it if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in Lyfe Rx's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Lyfe Rx is a provider we list only with full disclosure — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: No family, until the warning letter is resolved — read the FDA's own finding about its marketing claims before its price does the deciding.
Alternatives to Lyfe Rx
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Lyfe Rx
Head-to-head & alternatives
Lyfe Rx, answered
- Does Lyfe Rx have an FDA warning letter?
- Yes — an FDA warning letter dated 09/09/2025, addressed to thelyferx.com by name, over misleading claims about its compounded semaglutide and tirzepatide. Confirmed directly on FDA.gov; the site itself doesn't mention it.
Pricing, states and verification reflect Lyfe Rx's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.